Amylyx Pharmaceuticals, Inc. (AMLX)
13.85
-0.25
(-1.77%)
USD |
NASDAQ |
Mar 06, 16:00
13.88
+0.02
(+0.18%)
After-Hours: 20:00
Amylyx Pharmaceuticals SG&A Expense (TTM) : 62.89M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Rapt Therapeutics, Inc. | 29.76M |
| Disc Medicine, Inc. | 65.38M |
| Cytokinetics, Inc. | 284.27M |
| Ionis Pharmaceuticals, Inc. | 393.68M |
| MediciNova, Inc. | 6.159M |